Hepatitis A Virus
The Hepatitis A virus (HAV), or Hepatovirus A, is a virus of the Picornaviridae family. It takes human and vertebrates as its natural hosts. HAV isolates all belong to a single serotype, seven genetic groups now have been defined, four for humans (genotype number: I-III, and VII) and three for simian (genotype number: IV-VI). Hepatitis A is an infectious disease of the liver caused by the hepatitis A virus. HAV achieves about 1.4 million worldwide symptomatic cases per year and is the cause of Hepatitis A (formerly known as infectious hepatitis, an acute infectious disease of the liver). It is usually spread by eating food or drinking water contaminated with infected feces.| CAT | Product Name | Source | Product Overview | Target | Type | Datasheet | Size | Price |
|---|---|---|---|---|---|---|---|---|
| VAng-Lsx0156 | Inactivated HAV Antigen (Monkey) | Monkey | HAV, native protein from monkey. Inactivated native Hepatitis A Virus Antigen preparation is inactivated by incubating with formaldehyde for 96 hours. | Hepatitis A Virus | Viral Antigens |  |
-- | Inquiry |
| VAng-Lsx0157 | Inactivated HAV Antigen (Human) | Human | HAV-Antigen is prepared of the supernatant of infected Wannenstapel and dialysed against phosphat buffered saline. | Hepatitis A Virus | Viral Antigens | |
1 mL | Inquiry |
| VAng-Lsx0158 | Recombinant HAV Protein (aa 304-415) | Human | HAV (aa 304-415), recombinant protein from E. coli. | Hepatitis A Virus | Viral Antigens | |
-- | Inquiry |
| VAng-Lsx0159 | Recombinant HAV Protein (aa 5-164) | Human | HAV (aa 5-164), recombinant protein from E. coli. | Hepatitis A Virus | Viral Antigens | |
-- | Inquiry |
| VAng-Lsx0160 | Recombinant HAV Protein (aa 1392-1521) | Human | HAV (aa 1392-1521), recombinant protein from E. coli. | Hepatitis A Virus | Viral Antigens | |
100 µg | Inquiry |
| VAng-Lsx0161 | Recombinant HAV Protein (aa 1643-1743) | Human | HAV (aa 1643-1743), recombinant protein from E. coli. | Hepatitis A Virus | Viral Antigens | |
100 µg | Inquiry |
| VAng-Lsx0162 | Recombinant HAV Protein (aa 1121-1234) | Human | HAV (aa 1121-1234), recombinant protein from E. coli. | Hepatitis A Virus | Viral Antigens | |
-- | Inquiry |
| VAng-Lsx0163 | Recombinant HAV VP1 Protein (aa 502-605) | Human | Recombinant HAV VP protein containing amino acids 502-605 was expressed in E. coli and purified by proprietary chromatographic technique. | Hepatitis A Virus | Viral Antigens | |
100 µg | Inquiry |
| VAng-Lsx0164 | Recombinant HAV VP1-P2A Protein (aa 722-830) | Human | HAV VP1-P2A (aa 722-830), recombinant protein from E. coli. | Hepatitis A Virus | Viral Antigens | |
100 µg | Inquiry |
| VAng-Lsx0165 | Recombinant HAV VP1-P2A Protein (aa 669-782) | Human | HAV VP1-P2A (aa 669-782), recombinant protein from E. coli. | Hepatitis A Virus | Viral Antigens | |
100 µg | Inquiry |
| VAng-Lsx0166 | Recombinant HAV P2C-P3A Protein | Human | HAV P2C-P3A, recombinant protein from E. coli. | Hepatitis A Virus | Viral Antigens | |
100 µg | Inquiry |
| VAng-Lsx0167 | Recombinant HAV VP3 Protein | Human | HAV VP3, recombinant protein from E. coli. | Hepatitis A Virus | Viral Antigens | |
100 µg | Inquiry |
| VAng-Lsx0168 | Recombinant HAV VP4-VP2 Protein | Human | HAV VP4-VP2, recombinant protein from E. coli. | Hepatitis A Virus | Viral Antigens | |
100 µg | Inquiry |
| VAng-Lsx0169 | Recombinant HAV P2C Protein (aa 1121-1234) | Human | HAV P2C (aa 1121-1234), recombinant protein from E. coli. | Hepatitis A Virus | Viral Antigens | |
100 µg | Inquiry |
| VAng-Lsx0170 | Recombinant HAV P2C-P3A Protein (aa 1392-1521) | Human | HAV P2C-P3A (aa 1392-1521), recombinant protein from E. coli. | Hepatitis A Virus | Viral Antigens | |
100 µg | Inquiry |
| VAng-Lsx0171 | Recombinant HAV P3C Protein (aa 1643-1743) | Human | HAV P3C (aa 1643-1743), recombinant protein from E. coli. | Hepatitis A Virus | Viral Antigens | |
100 µg | Inquiry |
| VAng-Lsx0172 | Recombinant HAV VP1 Protein (aa 1-300) [His] | Human | HAV VP1 (aa 1-300) [His], recombinant protein from E. coli. | Hepatitis A Virus | Viral Antigens | |
100 µg | Inquiry |
| VAng-Lsx0173 | Recombinant HAV VP3 Protein (aa 248-491) [His] | Human | HAV VP3 (aa 248-491) [His], recombinant protein from E. coli. | Hepatitis A Virus | Viral Antigens | |
100 µg | Inquiry |
| VAng-Lsx0174 | Recombinant HAV VP4 Protein (aa 6-245) [His] | Human | HAV VP4 (aa 6-245) [His], recombinant protein from E. coli. | Hepatitis A Virus | Viral Antigens | |
100 µg | Inquiry |
| VAng-Lsx04578 | Inactivated HAV Antigen (Strain LV8) | Hepatitis A Virus (Strain LV8), native inactivated antigen. | Hepatitis A Virus | Viral Antigens | |
1 mL | Inquiry |
All of our products can only be used for research purposes. These vaccine ingredients CANNOT be used directly on humans or animals.
